Review of 1027 patients with newly diagnosed multiple myeloma.
about
michGranulopoiesis-stimulating factors for preventing infections after autologous peripheral stem cell transplantation for lymphoma and multiple myeloma in adultsAdditional plerixafor to granulocyte colony-stimulating factors for haematopoietic stem cell mobilisation for autologous transplantation in people with malignant lymphoma or multiple myelomaGranulopoiesis-stimulating factors for preventing infections after autologous peripheral stem cell transplantation for lymphoma and multiple myeloma in adultsAdditional plerixafor to granulocyte colony-stimulating factors for haematopoietic stem cell mobilisation for autologous transplantation in malignant lymphoma or multiple myeloma patientsA structurally distinct human mycoplasma protein that generically blocks antigen-antibody unionAdvances in understanding monoclonal gammopathy of undetermined significance as a precursor of multiple myelomaLong-term use of acetaminophen, aspirin, and other nonsteroidal anti-inflammatory drugs and risk of hematologic malignancies: results from the prospective Vitamins and Lifestyle (VITAL) studyCriteria for diagnosis, staging, risk stratification and response assessment of multiple myelomaPrognostic value of the serum free light chain ratio in newly diagnosed myeloma: proposed incorporation into the international staging systemSerum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significanceCurrent Trends of Renal Impairment in Multiple MyelomaThe Prevalence and Management of Multiple Myeloma-Induced Kidney Disease in ChinaAutoimmune manifestations in patients with multiple myeloma and monoclonal gammopathy of undetermined significanceMultiple myeloma in the very elderly patient: challenges and solutionsEfficacy and Safety of Novel Agent-Based Therapies for Multiple Myeloma: A Meta-AnalysisHypercalcemia of malignancy and new treatment optionsMolecular mechanisms in multiple myeloma drug resistanceBone formation following lenalidomide-dexamethasone combination therapy in cases of multiple myeloma refractory to high-dose chemotherapy with bortezomib and autologous peripheral blood stem cell transplantation: report of a case and review of the lEvidence-based case report: multiple thrombotic episodes associated with lenalidomide and dexamethasone therapy for multiple myelomaImmunoglobulin light chain amyloidosis: 2013 update on diagnosis, prognosis, and treatmentMultiple myeloma: 2014 Update on diagnosis, risk-stratification, and managementDiagnosis and treatment of bone disease in multiple myeloma: spotlight on spinal involvementNon-secretory multiple myeloma: from biology to clinical managementMechanism of Action of Bortezomib and the New Proteasome Inhibitors on Myeloma Cells and the Bone Microenvironment: Impact on Myeloma-Induced Alterations of Bone RemodelingMultiple myeloma epidemiology and survival: A unique malignancy.The role of SLAMF7 in multiple myeloma: impact on therapy.Paraprotein-Related Kidney Disease: Diagnosing and Treating Monoclonal Gammopathy of Renal Significance.Imaging Findings of Plasmacytoma of Both Breasts as a Preceding Manifestation of Multiple Myeloma.Imaging features of bilateral breast plasmacytoma as unusual initial presentation of multiple myeloma: case report and literature review.Multiple myeloma presenting as spinal cord compression: a case report.Long-term outcome of patients with multiple myeloma after autologous hematopoietic cell transplantation and nonmyeloablative allografting.Role of dynamic contrast-enhanced sonography for characterization and monitoring of extramedullary myeloma: comparison with serologic data.Magnetic resonance evaluation of multiple myeloma at 3.0 Tesla: how do bone marrow plasma cell percentage and selection of protocols affect lesion conspicuity?Treatment of multiple myeloma bone disease: experimental and clinical data.Berbamine, a novel nuclear factor kappaB inhibitor, inhibits growth and induces apoptosis in human myeloma cells.Plasma cell tumors in HIV-positive patients: report of a case and review of the literature.Renal failure in multiple myeloma: incidence, correlations, and prognostic significance.Use of bortezomib as induction therapy prior to stem cell transplantation in frontline treatment of multiple myeloma: impact on stem cell harvesting and engraftment.Bortezomib in patients with renal impairment.Chronic kidney disease stage 5 as the prognostic complement of International Staging System for multiple myeloma.
P2860
Q24186266-335B0108-CF37-4A96-834C-2A21F2543067Q24186469-0767BAB3-B31A-4CE3-A1C0-CA3CBCDD7894Q24200850-36F437E2-2213-4EFD-874D-96B3A34C77E2Q24202384-AC273C65-5CF0-4277-8CF7-65F871CE2459Q24568048-544F04E6-A3EB-4DCF-AF9D-542E2AC12C7CQ24619589-9F1C5E75-9E2F-4101-BAEB-65A902EF7171Q24626410-F4D94A9B-B5F3-4BCA-B1AC-57BCB1486870Q24647620-493D33A1-0710-46C2-96F6-9412B3D415B1Q24653434-DEF5012B-25B5-4037-959A-B0DBF08B4C92Q24669898-FB424120-4BFA-4DAC-9D06-36B13EED2FC8Q26740444-1F845990-1696-438C-93D6-89EDE3FF6D8CQ26740446-818FC993-BF57-4005-9F4C-EE8468790212Q26743454-E6E191D1-4EF2-4703-B9F8-E2825450A0BFQ26752991-4C551E67-7632-4DF9-9922-A2B793C8634EQ26767418-320496C6-DFAD-47D4-B4CF-6A91B5C16F61Q26775300-C9A3D20A-060A-41DB-880F-6864F77B9AAEQ26776386-E32081EC-C7C8-4E34-AA0F-A42E0C7618BCQ26783464-4C566063-40CA-4661-8060-DF48C6548F15Q26823292-9CD1FE34-290D-4F43-8C6C-E5F523A7CD2EQ26827340-356A7A97-343A-4CB7-9B2C-AE6A12DAD937Q26998884-B464D2B9-AB70-4CF2-9980-83F7AE65D4C5Q27011865-63D49B6F-A028-45F8-8E39-300C0E077245Q28074785-CEE59617-D7E1-4F23-822C-B8B662AD30A0Q28082335-5CD04F5E-70EC-4B74-B4EF-937833B21FF2Q30239771-B3E3DC28-5BB9-4C9F-9B42-5F4278941B78Q30249167-07E1D8CF-2D7A-47C1-8291-3052B0232DC4Q30276115-8D513A72-1759-417E-AF91-ABFB2B4F07BBQ30390127-20331933-C4E2-40FB-B304-BFBEF9085963Q30422627-C6BCBFF5-1849-4499-812D-7FC6C935EF5AQ30435038-157F22A4-7DDE-429F-9DD2-E18BB189CDB6Q30486842-4C393D4C-17F3-49F9-A929-DD335C04001BQ30669943-53EFFFA7-2DE0-4544-B438-15A0600A0098Q30747155-73E675F4-9944-4C84-B06D-D576331C72D9Q30868833-16F370D9-ACB5-40D0-BF56-4BF9C13BD5A0Q30952817-44C51399-A2BD-4EBA-8C2D-EC5356578D79Q30994410-30F8CE6B-61A6-432A-AF2D-9560D1996DBCQ33374368-27575A46-FEB0-4FD6-AB0F-CB92A44EF107Q33376918-63BE97ED-94ED-44B2-824B-FDE1A79F7EA4Q33396250-3CCD493D-2F2F-4677-8571-723E902700A4Q33397490-ABF3031D-93D9-47D1-8808-161932C9DA3C
P2860
Review of 1027 patients with newly diagnosed multiple myeloma.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Review of 1027 patients with newly diagnosed multiple myeloma.
@en
type
label
Review of 1027 patients with newly diagnosed multiple myeloma.
@en
prefLabel
Review of 1027 patients with newly diagnosed multiple myeloma.
@en
P2093
P50
P356
P1476
Review of 1027 patients with newly diagnosed multiple myeloma.
@en
P2093
Dirk R Larson
Janice R Offord
John A Lust
Matthew E Plevak
Philip R Greipp
Rafael Fonseca
Terry M Therneau
Thomas E Witzig
P356
10.4065/78.1.21
P407
P577
2003-01-01T00:00:00Z